There are 1193 resources available
Closing Remarks
Presenter: Salvatore Siena
Session: Seagen - HER2-Targeted Therapies in mCRC: Are We Ready for a Paradigm Shift?
Resources:
Webcast
Concluding Remarks
Presenter: Javier Cortés
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
Summary and close
Presenter: Ignacio Duran Martinez
Session: Astellas Pharma Europe Ltd - The evolving treatment landscape in LA/mUC
Resources:
Webcast